國立虎尾科技大學 |

Emerging concepts targeting immune checkpoints in cancer and autoimmunity

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Emerging concepts targeting immune checkpoints in cancer and autoimmunity/ edited by Akihiko Yoshimura.
其他作者:	Yoshimura, Akihiko.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	viii, 267 p. :digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Immune response - Regulation. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-68929-6
ISBN:	9783319689296

Emerging concepts targeting immune checkpoints in cancer and autoimmunity
Emerging concepts targeting immune checkpoints in cancer and autoimmunity[electronic resource] /edited by Akihiko Yoshimura. - Cham :Springer International Publishing :2017. - viii, 267 p. :digital ;24 cm. - Current topics in microbiology and immunology,v.4100070-217X ;. - Current topics in microbiology and immunology ;v.355..

Regulatory T cells: molecular and cellular basis for immunoregulation -- Overview of LAG-3- expressing, IL-10-producing regulatory T cells -- Regulatory Dendritic Cells -- Role of PD-1 in immunity and diseases -- CTLA-4, an essential immune-checkpoint for T cell activation -- Tim-3, Lag-3, and TIGIT -- SOCS1: regulator of T cells in autoimmunity and cancer -- Mining the complex family of protein tyrosine phosphatases for checkpoint regulators in immunity -- Immune regulation by ubiquitin tagging as checkpoint code -- MicroRNA in Immune Regulation.

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1) It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to "molecules and cells that negatively regulate T-cell activation". Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases. Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

ISBN: 9783319689296

Standard No.: 10.1007/978-3-319-68929-6doiSubjects--Topical Terms:

788586
Immune response
--Regulation.

LC Class. No.: QR186

Dewey Class. No.: 571.9646

Emerging concepts targeting immune checkpoints in cancer and autoimmunity
LDR:02653nam a2200325 a 4500 001 921827
003 DE-He213
005 20180511143202.0
006 m d
007 cr nn 008maaau
008 190624s2017 gw s 0 eng d
020 $a 9783319689296 $q (electronic bk.)
020 $a 9783319689289 $q (paper)
024 7 $a 10.1007/978-3-319-68929-6 $2 doi
035 $a 978-3-319-68929-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR186
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 571.9646 $2 23
090 $a QR186 $b .E53 2017
245 0 0 $a Emerging concepts targeting immune checkpoints in cancer and autoimmunity $h [electronic resource] / $c edited by Akihiko Yoshimura.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 267 p. : $b digital ; $c 24 cm.
490 1 $a Current topics in microbiology and immunology, $x 0070-217X ; $v v.410
505 0 $a Regulatory T cells: molecular and cellular basis for immunoregulation -- Overview of LAG-3- expressing, IL-10-producing regulatory T cells -- Regulatory Dendritic Cells -- Role of PD-1 in immunity and diseases -- CTLA-4, an essential immune-checkpoint for T cell activation -- Tim-3, Lag-3, and TIGIT -- SOCS1: regulator of T cells in autoimmunity and cancer -- Mining the complex family of protein tyrosine phosphatases for checkpoint regulators in immunity -- Immune regulation by ubiquitin tagging as checkpoint code -- MicroRNA in Immune Regulation.
520 $a This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1) It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to "molecules and cells that negatively regulate T-cell activation". Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases. Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.
650 0 $a Immune response $x Regulation. $3 788586
650 0 $a Cancer $x Immunological aspects. $3 785620
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Immunology. $3 592892
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Cell Biology. $3 593889
700 1 $a Yoshimura, Akihiko. $3 1197006
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Current topics in microbiology and immunology ; $v v.355. $3 882363
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-68929-6
950 $a Biomedical and Life Sciences (Springer-11642)